Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Health Aff (Millwood). 2018 Dec;37(12):2014–2023. doi: 10.1377/hlthaff.2018.05091

Exhibit 2:

Antibiotic Use, Broad-Spectrum Antibiotic Use, and Guideline-Concordant Antibiotic Management across Settings in the Unmatched and Matched Sample, 2015–2016

Unmatched Visits Matched Visits
DTC Telemedicine PCP Urgent Care DTC Telemedicine PCP Urgent Care
Overall (N) 39,974 1,084,056 212,837 38,839 942,613 186,016
N % N % N % N % N % N %
Any Antibiotic Usea 20,839 52 544,105 50*** 113,769 53*** 20,231 52 497,941 53** 105,048 56***
Broad-Spectrum Antibiotics Useb 10,932 27 302,020 28* 54,829 26*** 10,627 27 273,628 29*** 52,985 28***
Guideline-Concordant Antibiotic Managementc 24,767 62 660,582 61*** 128,731 60*** 24,055 62 568,949 60*** 110,095 59***

Source: Authors’ analysis of data from 2015-2016 claims from a large national insurer.

Notes: Abbreviations: DTC, direct to consumer; PCP, primary care provider.

a

Visits with antibiotic use include those categorized as guideline-concordant use, guideline non-concordant use, and unnecessary antibiotic use.

b

Broad-spectrum antibiotics were defined as macrolides (excluding erythromycin), fluoroquinolones, and non-first-generation cephalosporins.

c

Visits with guideline-concordant antibiotic management include those categorized as guideline-concordant antibiotic use, guideline-concordant non-use of antibiotics, or, for visits with a diagnosis of acute otitis media or sinusitis, no antibiotic use. Hypothesis testing performed using chi-square tests, comparing DTC telemedicine visits to PCP visits and to urgent care visits

*

p<0.05;

**

p<0.01;

***

p<0.001